STEK Stock Overview
A stem cell nutrition company, develops science-based products to help the body maintain healthy stem cell physiology in the Americas, Latin America, and Asia. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Stemtech Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.048 |
| 52 Week High | US$0.10 |
| 52 Week Low | US$0.01 |
| Beta | 2.24 |
| 1 Month Change | -12.98% |
| 3 Month Change | 15.20% |
| 1 Year Change | 52.32% |
| 3 Year Change | -98.64% |
| 5 Year Change | n/a |
| Change since IPO | -98.46% |
Recent News & Updates
Recent updates
Shareholder Returns
| STEK | US Personal Products | US Market | |
|---|---|---|---|
| 7D | 0.7% | -4.5% | -2.7% |
| 1Y | 52.3% | -24.7% | 23.4% |
Return vs Industry: STEK exceeded the US Personal Products industry which returned -24.7% over the past year.
Return vs Market: STEK exceeded the US Market which returned 23.4% over the past year.
Price Volatility
| STEK volatility | |
|---|---|
| STEK Average Weekly Movement | 36.1% |
| Personal Products Industry Average Movement | 8.2% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.9% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: STEK's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: STEK's weekly volatility has increased from 26% to 36% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | n/a | Charles Arnold | www.stemtech.com |
Stemtech Corporation, a stem cell nutrition company, develops science-based products to help the body maintain healthy stem cell physiology in the Americas, Latin America, and Asia. Its products enhance and support the work of the body’s stem cells by releasing more stem cells, helping to circulate them in the blood, and migrate them into tissues, where they can perform their daily function of renewal for optimal health. The company offers its dietary supplements products under the RCM System, stemrelease3, Stemflo MigraStem, and OraStem brand names; and skincare products under the Cellect One brand name.
Stemtech Corporation Fundamentals Summary
| STEK fundamental statistics | |
|---|---|
| Market cap | US$6.46m |
| Earnings (TTM) | -US$5.24m |
| Revenue (TTM) | US$5.10m |
1.3x
P/S Ratio-1.2x
P/E RatioIs STEK overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| STEK income statement (TTM) | |
|---|---|
| Revenue | US$5.10m |
| Cost of Revenue | US$1.28m |
| Gross Profit | US$3.82m |
| Other Expenses | US$9.06m |
| Earnings | -US$5.24m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.039 |
| Gross Margin | 74.96% |
| Net Profit Margin | -102.67% |
| Debt/Equity Ratio | -74.8% |
How did STEK perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 04:27 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Stemtech Corporation is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|